(edap) may skyrocket this morning. Company is big into ultrasound (31 Mil sales) and new study reported that ultrasound works very successfully on prostate cancer without the side effects of other remedies. Edap is applying to the FDA for approval in lucrative US market. The stock broke out of an upward channel yesterday on high volume. Looks good for quick or long term.